Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence (Q29618819)

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Structural brain imaging in schizophrenia: a selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A review of MRI findings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis of brain weight in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis of thalamic size in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Regionally localized thinning of the cerebral cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Cortical abnormality in schizophrenia: an in vivo application of the gyrification index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Cerebral gray matter volume deficits in first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Magnetic resonance imaging of brain in people at high risk of developing schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Brains at risk of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The brain in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

From neuropathology to neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Ventricular enlargement in poor-outcome schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Defining the course of brain structural change and plasticity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Absence of Neurodegeneration and Neural Injury in the Cerebral Cortex in a Sample of Elderly Patients With Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

No increased incidence of Alzheimer's disease in elderly schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell-counting study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia: the cellular biology of a functional psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia: a disorder of neurodevelopment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Cytoarchitecture of the entorhinal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Size of hippocampal pyramidal neurons in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Presynaptic proteins and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Hippocampal neuron number in schizophrenia. A stereological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Subnucleus-specific loss of neurons in medial thalamus of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Volumes of association thalamic nuclei in schizophrenia: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Low medial and lateral right pulvinar volumes in schizophrenia: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Electron microscopy of oligodendroglia in severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Mitochondrial involvement in schizophrenia and other functional psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Proton magnetic resonance spectroscopy in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The reduced neuropil hypothesis: a circuit based model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The neuropathological effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Pre‐and Postmortem Influences on Brain RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Differences between smokers and nonsmokers in regional gray matter volumes and densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia as a disorder of developmentally reduced synaptic connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The synaptic hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

White matter changes in schizophrenia: evidence for myelin-related dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Cerebellar synaptic protein expression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Glutamatergic mechanisms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Decreased thalamic expression of the homeobox gene DLX1 in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A polygenic theory of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The molecular genetics of schizophrenia: new findings promise new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A systematic genomewide linkage study in 353 sib pairs with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

"Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genetics of Lactase Persistence and Lactose Intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

How many diseases does it take to map a gene with SNPs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia and velo-cardio-facial syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Distribution of catechol-O-methyltransferase expression in human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

3-Methoxytyramine Is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Sim

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Prefrontal neurons and the genetics of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A highly significant association between a COMT haplotype and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The activities of brain dopamine-?-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

beta-dystrobrevin, a member of the dystrophin-related protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Proteomic analysis of NMDA receptor-adhesion protein signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The dynamic organization of postsynaptic proteins: translocating molecules regulate synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulin 1 and susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association of neuregulin 1 with schizophrenia confirmed in a Scottish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association study of neuregulin 1 gene with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A case control and family based association study of the neuregulin1 gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulins: functions, forms, and signaling strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulin 1 and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulin and ErbB receptor signaling pathways in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulin signaling via erbB receptor assemblies in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Back signaling by the Nrg-1 intracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulins and the shaping of synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Gene targeting reveals multiple essential functions of the neuregulin signaling system during development of the neuroendocrine and nervous systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuregulin-1beta modulates in vivo entorhinal-hippocampal synaptic transmission in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Axonal neuregulin-1 regulates myelin sheath thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association and linkage analyses of RGS4 polymorphisms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Support for RGS4 as a susceptibility gene for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Confirming RGS4 as a susceptibility gene for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Regional expression of RGS4 mRNA in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The regulator of G protein signaling family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Opposite modulation of regulators of G protein signalling-2 RGS2 and RGS4 expression by dopamine receptors in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association within a family of a balanced autosomal translocation with major mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Disruption of two novel genes by a translocation co-segregating with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Chromosome 1 loci in Finnish schizophrenia families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Linkage of schizophrenia with chromosome 1q loci in Taiwanese families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Replication of 1q42 linkage in Finnish schizophrenia pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genetic linkage and association between chromosome 1q and working memory function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Yeast two-hybrid screens implicate DISC1 in brain development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

DISC1 (Disrupted in Schizophrenia-1) is expressed in limbic regions of the primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Expression of Disrupted-In-Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The genetics of schizophrenia: glutamate not dopamine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Regulation of neurotransmitter release by metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Molecular determinants of metabotropic glutamate receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Molecular characterization and localization of human metabotropic glutamate receptor type 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Roles of serine/threonine phosphatases in hippocampal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Calcineurin regulation of neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The neurobiology of slow synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

DARPP-32: an integrator of neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The absence of a major Ca 2+ signaling pathway in GABAergic neurons of the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuronal nicotinic receptors in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Nicotinic receptors on local circuit neurons in dentate gyrus: a potential role in regulation of granule cell excitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A Cysteine-Rich Isoform of Neuregulin Controls the Level of Expression of Neuronal Nicotinic Receptor Channels during Synaptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Comparison of the regional expression of nicotinic acetylcholine receptor ?7 mRNA and [125I]-?-bungarotoxin binding in human postmortem brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genetic variation in the 22q11 locus and susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

PRODH mutations and hyperprolinemia in a subset of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The gene encoding proline dehydrogenase modulates sensorimotor gating in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Proline, glutamate and glutamine metabolism in mouse brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Proline-induced inhibition of glutamate release in hippocampal area CA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

A family-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Failure to find association between PRODH deletion and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Association between PRODH and schizophrenia is not confirmed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

GSK-3 and the neurodevelopmental hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

PKB binding proteins. Getting in on the Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Alternative splicing in the nervous system: an emerging source of diversity and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Single-nucleotide polymorphisms can cause different structural folds of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Polymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

DNA methylation in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Genes for schizophrenia? Recent findings and their pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Bringing order to the glutamate chaos in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Control of synaptic strength, a novel function of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The neuropathology of primary mood disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Rett Syndrome -- an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Postnatal Neurodevelopmental Disorders: Meeting at the Synapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

The amyloid hypothesis: let sleeping dogmas lie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Alzheimer's disease: one disorder, too many genes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Immunocytochemical localization of D-amino acid oxidase in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

Disturbed Gyrification of the Prefrontal Region in Male Schizophrenic Patients: A Morphometric Postmortem Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Schizophrenia: evidence of a subgroup with reversed cerebral asymmetry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Reduced gray matter volume in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Structural Brain Abnormalities in Patients With Schizophrenia and Their Healthy Siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Variability in the Human Entorhinal Region May Confound Neuropsychiatric Diagnoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

The role of synaptic morphology in neural plasticity: structural interactions underlying synaptic power

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Emerging principles of altered neural circuitry in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Schizophrenia and glutamatergic transmission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Preferential transmission of the high activity allele of COMT in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Family-based association study of DTNBP1 in 6p22.3 and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Mutation analysis of the human dystrobrevin-binding protein 1 gene in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Brain dystrophin, neurogenetics and mental retardation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Cis-acting variation in the expression of a high proportion of genes in human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Polymorphisms within 5' end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

No association with the neuregulin 1 haplotype to Japanese schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Dynamic expression of RGS4 in the developing nervous system and regulation by the neural type-specific transcription factor Phox2b.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

The origin and neuronal function of in vivo nonsynaptic glutamate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Smoking and mental illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021

The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001558

7 January 2021